BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 33426772)

  • 41. Complete sequence of human T cell leukemia virus type 1 in ATLL patients from Northeast Iran, Mashhad revealed a prematurely terminated protease and an elongated pX open reading frame III.
    Mirhosseini A; Mohareri M; Arab R; Rezaee SA; Shirdel A; Koshyar MM; Allahyari A; Bari A; Rahimi H; Mozaheb Z; Bazarbachi A; Boostani R; Mashkani B; Rafatpanah H
    Infect Genet Evol; 2019 Sep; 73():460-469. PubMed ID: 31102740
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of HTLV-1 by polymerase chain reaction in situ hybridization in adult T-cell leukemia/lymphoma.
    Setoyama M; Kerdel FA; Elgart G; Kanzaki T; Byrnes JJ
    Am J Pathol; 1998 Mar; 152(3):683-9. PubMed ID: 9502410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Osteolytic bone resorption in adult T-cell leukemia/lymphoma.
    Shu ST; Martin CK; Thudi NK; Dirksen WP; Rosol TJ
    Leuk Lymphoma; 2010 Apr; 51(4):702-14. PubMed ID: 20214446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutation analysis of mitotic checkpoint genes (hBUB1 and hBUBR1) and microsatellite instability in adult T-cell leukemia/lymphoma.
    Ohshima K; Haraoka S; Yoshioka S; Hamasaki M; Fujiki T; Suzumiya J; Kawasaki C; Kanda M; Kikuchi M
    Cancer Lett; 2000 Oct; 158(2):141-50. PubMed ID: 10960763
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Smoking is a risk factor for development of adult T-cell leukemia/lymphoma in Japanese human T-cell leukemia virus type-1 carriers.
    Kondo H; Soda M; Sawada N; Inoue M; Imaizumi Y; Miyazaki Y; Iwanaga M; Tanaka Y; Mizokami M; Tsugane S
    Cancer Causes Control; 2016 Sep; 27(9):1059-66. PubMed ID: 27412633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan.
    Iwanaga M; Watanabe T; Utsunomiya A; Okayama A; Uchimaru K; Koh KR; Ogata M; Kikuchi H; Sagara Y; Uozumi K; Mochizuki M; Tsukasaki K; Saburi Y; Yamamura M; Tanaka J; Moriuchi Y; Hino S; Kamihira S; Yamaguchi K;
    Blood; 2010 Aug; 116(8):1211-9. PubMed ID: 20448111
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene expression and TCR amino acid sequences selected by HLA-A02:01-restricted CTLs specific to HTLV-1 in ATL patients.
    Kusuda M; Nakasone H; Yoshimura K; Okada Y; Tamaki M; Matsuoka A; Ishikawa T; Meno T; Nakamura Y; Kawamura M; Takeshita J; Kawamura S; Yoshino N; Misaki Y; Gomyo A; Tanihara A; Kimura SI; Kako S; Kanda Y
    Br J Haematol; 2023 Aug; 202(3):578-588. PubMed ID: 37317804
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutational Intratumor Heterogeneity is a Complex and Early Event in the Development of Adult T-cell Leukemia/Lymphoma.
    Farmanbar A; Firouzi S; Makałowski W; Kneller R; Iwanaga M; Utsunomiya A; Nakai K; Watanabe T
    Neoplasia; 2018 Sep; 20(9):883-893. PubMed ID: 30032036
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PRMT5 Is Upregulated in HTLV-1-Mediated T-Cell Transformation and Selective Inhibition Alters Viral Gene Expression and Infected Cell Survival.
    Panfil AR; Al-Saleem J; Howard CM; Mates JM; Kwiek JJ; Baiocchi RA; Green PL
    Viruses; 2015 Dec; 8(1):. PubMed ID: 26729154
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic variability and molecular epidemiology of human and simian T cell leukemia/lymphoma virus type I.
    Gessain A; Mahieux R; de Thé G
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S132-45. PubMed ID: 8797716
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of HTLV-1 proviral load, LAT, BIM, c-FOS and RAD51 gene expression in adult T cell leukemia/lymphoma.
    Ramezani S; Shirdel A; Rafatpanah H; Akbarin MM; Tarokhian H; Rahimi H; Bari A; Jahantigh HR; Rezaee SA
    Med Microbiol Immunol; 2017 Aug; 206(4):327-335. PubMed ID: 28466382
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aberrant expression of the p53 tumor suppressor gene in adult T-cell leukemia and HTLV-I-infected cells.
    Yamato K; Oka T; Hiroi M; Iwahara Y; Sugito S; Tsuchida N; Miyoshi I
    Jpn J Cancer Res; 1993 Jan; 84(1):4-8. PubMed ID: 8449826
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of microRNAs in HTLV-1 infection and transformation.
    Ruggero K; Corradin A; Zanovello P; Amadori A; Bronte V; Ciminale V; D'Agostino DM
    Mol Aspects Med; 2010 Oct; 31(5):367-82. PubMed ID: 20600265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Karyotypic complexity, TP53 pathogenic variants, and increased number of variants on Next-Generation Sequencing are associated with disease progression in a North American Adult T-Cell Leukemia/Lymphoma cohort.
    Zhang X; Shi Y; Ramesh KH; Naeem R; Wang Y
    Int J Lab Hematol; 2021 Aug; 43(4):651-657. PubMed ID: 33988304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma.
    Rauch DA; Olson SL; Harding JC; Sundaramoorthi H; Kim Y; Zhou T; MacLeod AR; Challen G; Ratner L
    Retrovirology; 2020 Aug; 17(1):27. PubMed ID: 32859220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Experimental acute adult T cell leukemia-lymphoma is associated with thymic atrophy in human T cell leukemia virus type I infection.
    Simpson RM; Zhao TM; Hubbard BS; Sawasdikosol S; Kindt TJ
    Lab Invest; 1996 Mar; 74(3):696-710. PubMed ID: 8600320
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Zidovudine and interferon-alpha treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran.
    Kchour G; Makhoul NJ; Mahmoudi M; Kooshyar MM; Shirdel A; Rastin M; Rafatpanah H; Tarhini M; Zalloua PA; Hermine O; Farid R; Bazarbachi A
    Leuk Lymphoma; 2007 Feb; 48(2):330-6. PubMed ID: 17325893
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distinct gene expression signatures induced by viral transactivators of different HTLV-1 subgroups that confer a different risk of HAM/TSP.
    Naito T; Yasunaga JI; Mitobe Y; Shirai K; Sejima H; Ushirogawa H; Tanaka Y; Nakamura T; Hanada K; Fujii M; Matsuoka M; Saito M
    Retrovirology; 2018 Nov; 15(1):72. PubMed ID: 30400920
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic alterations in adult T-cell leukemia/lymphoma.
    Kogure Y; Kataoka K
    Cancer Sci; 2017 Sep; 108(9):1719-1725. PubMed ID: 28627735
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations.
    Cesarman E; Chadburn A; Inghirami G; Gaidano G; Knowles DM
    Blood; 1992 Dec; 80(12):3205-16. PubMed ID: 1361372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.